Independent Community Pharmacy Stakeholder-Informed Dispensing Fee Reform: A Cross-Sectional Survey.

Ziyanda Ndlangisa; Vivian Naidoo; Ruwayda Petrus; Sarentha Chetty; Varsha Bangalee

doi:10.51168/76jer991

Autori

Ziyanda Ndlangisa PhD candidate, Discipline of Pharmaceutical Sciences, Westville Campus, University of KwaZulu-Natal, Durban, South Africa.
Vivian Naidoo Honorary Research Fellow, Discipline of Pharmaceutical Sciences, Westville Campus, University of KwaZulu-Natal, Durban, South Africa.
Ruwayda Petrus Senior Lecturer, Discipline of Psychology, School of Applied Human Sciences, University of KwaZulu-Natal, Durban, South Africa.
Sarentha Chetty Senior Lecturer, Discipline of Pharmaceutical Sciences, Westville Campus, University of KwaZulu-Natal, Durban, South Africa.
Varsha Bangalee Head of School, Discipline of Pharmaceutical Sciences, Westville Campus, University of KwaZulu-Natal, Durban, South Africa.

DOI:

https://doi.org/10.51168/76jer991

Cuvinte cheie:

prices, dispensing, medicine policy, pharmaceutical policy, medical aid scheme

Rezumat

Background:

The South African four-tier dispensing fee was formally implemented in 2010. The fee structure was determined using a zero-based model and a return-on-investment dispensary cost, with the assumption that a well-run pharmacy dispenses 2300 items per month. The fee structure has significant implications for the viability of independent community pharmacies.

Objectives:

To quantitatively examine the current dispensing fee structures' influence on service delivery at independent community pharmacies in the KwaZulu-Natal province and to propose independent community pharmacy stakeholder-informed priorities for fee revision.

Methods:

A descriptive cross-sectional online survey was conducted between 5 December 2025 and 28 February 2026 among pharmacy owners, responsible pharmacists, and pharmacists working at independently owned pharmacies in the KwaZulu-Natal province. Chi-square tests were used to assess associations, and a binary logistic regression was used to identify predictors. All data analysis was done at a level of significance.

Results:

Male respondents represented 58.2% of the sample, with female respondents representing 41.8%. The majority of the respondents were from peri-urban locations (48.6%). Sixty-one of the 146 respondents (41.8%) reported service changes in response to the fee structure. Pharmacies dispensing less than 2300 items per month were more likely to offer additional services than those dispensing at/above 2300. Years of community pharmacy experience were a significant predictor of service adaptation (AOR 6.13; 95% CI 1.013-1.114, p=0.13).

Conclusion:

Survey findings suggest the current dispensing fee structure may be context-blind, with respondents dispensing below the 2300 items per month threshold being pushed to adopt innovative strategies to ensure practice viability. Respondents with more years of experience were more likely to provide additional services at their pharmacies.

Recommendations:

The fee structure needs to incorporate actual pharmacy operational costs and location. Future research should consider adopting qualitative methods to explore viable options to align the dispensing fee structure with actual pharmacy operations.

Biografie autor

Ziyanda Ndlangisa, PhD candidate, Discipline of Pharmaceutical Sciences, Westville Campus, University of KwaZulu-Natal, Durban, South Africa.

is a PhD candidate at the University of KwaZulu-Natal, Discipline of Pharmaceutical Sciences. She is also a registered pharmacist with the South African Pharmacy Council and conducted this research as part of her ongoing PhD study.

Referințe

1. Andy Gray, F. S. (2015). Pharmaceutical pricing in South Africa. In Z-U-D.Babar (Ed.), Pharmaceutical Prices in the 21st Century. Springer International. https://doi.org/10.1007/978-3-319-12169-7

2. Bangalee, V., & Suleman, F. (2016). Has the increase in the availability of generic drugs lowered the price of cardiovascular drugs in South Africa? Health SA Gesondheid, 21, 60–66. https://doi.org/10.1016/j.hsag.2015.10.004

3. Bangalee, V., & Suleman, F. (2019). Pseudo-Generics in South Africa: A Price Comparison. Value in Health Regional Issues, 19, 87–91. https://doi.org/10.1016/j.vhri.2019.06.001

4. Bratkowska, K., Religioni, U., Krysiński, J., & Merks, P. (2020). Quality of pharmaceutical services in independent pharmacies and pharmacy chains in Poland from the patient perspective. Patient Preference and Adherence, 14, 2459–2467. https://doi.org/10.2147/PPA.S284014

5. Cardoso, T. C., Simoens, S., Itria, A., & Dewulf, N. de L. S. (2020). Cost analysis of a medication dispensing service in community pharmacy in Brazil. Brazilian Journal of Pharmaceutical Sciences, 56, 1–12. https://doi.org/10.1590/S2175-97902019000418715

6. Ceka, A., Juneja, B., Tseng, O., Zhang, W., Kuo, I. F., Bansback, N., Law, M. R., Lynd, L. D., Zed, P. J., & Mitton, C. (2026). Bridging the gap between expanded pharmacy services and payment models: A jurisdictional scan. Journal of the American Pharmacists Association, 66(1), 102989. https://doi.org/10.1016/j.japh.2025.102989

7. Cho, Y. I., Johnson, T. P., & Vangeest, J. B. (2013). Enhancing Surveys of Health Care Professionals: A Meta-Analysis of Techniques to Improve Response. https://doi.org/10.1177/0163278713496425

8. Chong, W. W., Aslani, P., & Chen, T. (2013). Adherence to antidepressant medications: an evaluation of community pharmacists & amp; rsquo; counseling practices [Corrigendum]. Patient Preference and Adherence, 1059. https://doi.org/10.2147/PPA.S54761

9. Constitutional Court of South Africa. (2005). Minister of Health and Another v New Clicks South Africa (Pty) Ltd and Others: Vol. CCT59/2004. Constitutional Court of South Africa. https://www.saflii.org/za/cases/ZACC/2005/14.pdf

10. Cook, J. V, Dickinson, H. O., & Eccles, M. P. (2009). Response rates in postal surveys of healthcare professionals between 1996 and 2005 : An observational study. 8, 1–8. https://doi.org/10.1186/1472-6963-9-160

11. Council for Medical Schemes. (n.d.). Council for Medical Schemes: Annual Report 2024/25. https://static.pmg.org.za/CMS_-_Council_for_Medical_Schemes_Annual_Report_2024-2025.pdf

12. de Jager, H., & Suleman, F. (2019). The impact of generics and generic reference pricing on candesartan and rosuvastatin utilisation, price and expenditure in South Africa. International Journal of Clinical Pharmacy, 41(1), 81–87. https://doi.org/10.1007/s11096-018-0758-x

13. de Souza, E. V., Vieira, L. J. S. C., dos Santos, S. N. P., Cerqueira-Santos, S., Rocha, K. S. S., & de Lyra, D. P. (2022). Antimicrobial dispensing process in community pharmacies: a scoping review. Antimicrobial Resistance and Infection Control, 11(1). https://doi.org/10.1186/s13756-022-01157-0

14. Government Gazette, V. 390 N. 18505. (1998). Medicines and Related Substances Control Amendment Act [No. 90 of 1997]. 90, 1–22. papers3://publication/uuid/4685983C-EA65-47A0-A43A-58F452BA28C7

15. Gray, A. L. (2009). Medicine pricing interventions – the South African experience. Southern Med Review, 2(2), 15–19.

16. Gray, A. L., Santa-Ana-Tellez, Y., & J. Wirtz, V. (2016). Impact of the introduction of mandatory generic substitution in South Africa: private sector sales of generic and originator medicines for chronic diseases. Tropical Medicine & International Health, 21(12), 1504–1512. https://doi.org/10.1111/tmi.12785

17. Guhl, D., Blankart, K. E., & Stargardt, T. (2019). Service quality and perceived customer value in community pharmacies. Health Services Management Research, 32(1), 36–48. https://doi.org/10.1177/0951484818761730

18. Mesquita, A. R., de Oliveira Sá, D. A. B., Santos, A. P. A. L., de Almeida Neto, A., & Lyra, D. P. (2013). Assessment of pharmacist’s recommendation of non-prescription medicines in Brazil: a simulated patient study. International Journal of Clinical Pharmacy, 35(4), 647–655. https://doi.org/10.1007/s11096-013-9787-7

19. Mobark, D. M., Al-Tabakha, M. M., & Hasan, S. (2019). Assessing hormonal contraceptive dispensing and counseling provided by community pharmacists in the united arab emirates: A simulated patient study. Pharmacy Practice, 17(2), 8–14. https://doi.org/10.18549/PharmPract.2019.2.1465

20. Moodley, R., & Suleman, F. (2019). Evaluating the impact of the single exit price policy on a basket of originator medicines in South Africa from 1999 to 2014 using a time series analysis. BMC Health Services Research, 19(1), 1–13. https://doi.org/10.1186/s12913-019-4403-8

21. Mpanza, N. M., Bradley, H., & Laing, R. (2019). Reasons why insured consumers co-pay for medicines at retail pharmacies in Pretoria, South Africa. African Journal of Primary Health Care & Family Medicine, 11(1). https://doi.org/10.4102/phcfm.v11i1.1878

22. National Department of Health, S. A. (1996). Medicines and Related Substances Act 101 of 1965.

23. Newman, T. V, Hernandez, I., Keyser, D., Rodriguez, A. S.-J., Swart, E. C. S., Shrank, W. H., & Parekh, N. (2019). Optimizing the Role of Community Pharmacists in Managing the Health of Populations: Barriers, Facilitators, and Policy Recommendations. Journal of Managed Care & Specialty Pharmacy, 25(9), 995–1000. https://doi.org/10.18553/jmcp.2019.25.9.995

24. Ngozwana, S. (2016). Policies to Control Prices of Medicines: Does the South African Experience Have Lessons for Other African Countries? In W. W. Mackintosh, M., Banda G., Tibandebage P. (Ed.), Making Medicines in Africa (pp. 203–223). Palgrave Macmillan. https://doi.org/10.1007/978-1-137-54647-0_12

25. Nicolosi, E., & Gray, A. (2009). Potential cost savings from generic medicines - Protecting the Prescribed Minimum Benefits. South African Family Practice, 51(1), 59–63. https://doi.org/10.1080/20786204.2009.10873809

26. Nyamuzihwa, T., Tembo, A., Martyn, N., Venter, F., Maimin, J., Houghton, J., & Lalla-Edward, S. T. (2023). The South African community pharmacy sector—an untapped reservoir for delivering HIV services. Frontiers in Reproductive Health, 5(July 2023), 1–5. https://doi.org/10.3389/frph.2023.1173576

27. Odeh, M., Hamed, S., Assab, M. A., Aldawahik, A. A., & Alhayek, M. (2025). Comparative analysis of pharmaceutical care, professional development, and policy compliance in chain vs. independent pharmacies: A Cross-sectional study. Pharmacy Practice, 23(3), 1–18. https://doi.org/10.18549/PharmPract.2025.3.3222

28. Pharmaceutical Society of South Africa. (2009). Dispensing Fee-PSF and Minister of Health agree to further discussions (Issue February).

29. Pukhov, O., Hoagland, A., & Grootendorst, P. (2026). The economics of community pharmacy in Canada. Part 2: A synthesis of the evidence on competitive strategies. Canadian Pharmacists Journal / Revue Des Pharmaciens Du Canada, 159(3), 194–201. https://doi.org/10.3138/cpj-25-0022

30. Rocha, K. S. S., Cerqueira Santos, S., Boaventura, T. C., dos Santos Júnior, G. A., de Araújo, D. C. S. A., Silvestre, C. C., de Jesus, E. M. S., & de Lyra Júnior, D. P. (2020). Development and content validation of an instrument to support pharmaceutical counselling for dispensing of prescribed medicines. Journal of Evaluation in Clinical Practice, 26(1), 134–141. https://doi.org/10.1111/jep.13102

31. Schellack, N. (2023). The health of pharmacy in South Africa: Navigating through the challenges. SA Pharmaceutical Journal, 90(6), 3–5. https://doi.org/10.10520/ejc-mp_sapj_v90_n6_a1

32. Schmidtke, K. A., & Warholak, T. (2025). Payment models and the sustainability of community pharmacy practice: a qualitative interview study with community pharmacists. Journal of Pharmaceutical Policy and Practice, 18(1). https://doi.org/10.1080/20523211.2025.2450018

33. Taylor, Cairns, & Glass. (2021). Expanded practice in rural community pharmacy: a macro-, meso- and micro-level perspective. Rural and Remote Health. https://doi.org/10.22605/RRH6158